Atoxim-S 1.5 gm Injection 1's

Atoxim-S 1.5 gm Injection belongs to the group of medicines called antibiotics. It is used to treat a wide variety of bacterial infections in the body. A bacterial infection is a condition in which harmful bacteria grow in the body and cause infection.

Atoxim-S 1.5 gm Injection contains Ceftizoxime (third-generation cephalosporin antibiotic) and Sulbactam (beta-lactamase inhibitor). It works by inhibiting the synthesis of the bacterial cell wall (a protective covering) that is necessary for their survival. This causes damage to the bacterial cell wall and eventually leads to the death of the bacterial cell. Sulbactam works by decreasing bacterial resistance and enhancing the activity of Ceftizoxime against the bacteria. Together, Atoxim-S 1.5 gm Injection helps treat bacterial infections.

Atoxim-S 1.5 gm Injection will be administered by a healthcare professional; do not self-administer. In some cases, Atoxim-S 1.5 gm Injection may cause injection site reactions, diarrhoea, nausea, vomiting, headache, rash, stomach upset, and indigestion. Most of these side effects of Atoxim-S 1.5 gm Injection do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Let your doctor know about your medical and medication history to avoid the occurrence of potential interactions. Atoxim-S 1.5 gm Injection should only be given during pregnancy when the need has been established. Hence, inform your doctor if you are pregnant, suspect you are pregnant or plan to have a baby; your doctor will weigh the benefits of Atoxim-S 1.5 gm Injection therapy against the risk to your baby. Breastfeeding should be avoided unless instructed by the doctor. Consumption of alcohol should be avoided while on treatment with Atoxim-S 1.5 gm Injection.

Atoxim-S 1.5 gm Injection is used in the treatment of various bacterial infections by combining the antibacterial actions of Ceftriaxone and Sulbactam. The detailed uses of Atoxim-S 1.5 gm Injection are as follows:

• Treats respiratory tract infections: Atoxim-S 1.5 gm Injection acts effectively against lung and sinus infections, including pneumonia, bronchitis, and sinusitis.
• Manages ENT infections: Atoxim-S 1.5 gm Injection is used for bacterial infections of the ear and throat such as otitis media and tonsillitis.
• Effective in urinary tract infections: Atoxim-S 1.5 gm Injection treats bladder and kidney infections caused by susceptible bacteria.
• Controls skin and soft tissue infections: It is indicated for cellulitis, wound infections, and other soft tissue infections.

• Follow your doctor's instructions on the dosage and timing of this medication.
• Atoxim-S 1.5 gm Injection will be administered by a healthcare professional.
• Do not self-administer it.

Atoxim-S 1.5 gm Injection contains Ceftizoxime and Sulbactam. Ceftizoxime is a third-generation cephalosporin antibiotic, and Sulbactam is a beta-lactamase inhibitor. It acts by blocking the synthesis of the bacterial cell wall, which is required for their survival. This damages the bacterial cell wall and eventually kills the bacterial cell. Sulbactam reduces bacterial resistance while increasing the activity of Ceftizoxime against bacteria. Together, Atoxim-S 1.5 gm Injection helps to treat bacterial infections.

Before taking the Atoxim-S 1.5 gm Injection, inform your doctor about all of your medical problems, sensitivities, and drugs. If you are pregnant or breastfeeding, check with your doctor before taking Atoxim-S 1.5 gm Injection. For effective outcomes, it is recommended that you complete the entire course of Atoxim-S 1.5 gm Injection as prescribed by your doctor. If you are received or scheduled for immunizations, inform your doctor. Atoxim-S 1.5 gm Injection should be used cautiously in people with Clostridium difficile-associated diarrhoea.